KRAS inhibitors MRTX1133 or daraxonrasib synergize with anti-CTLA4 in pancreatic cancer
A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...
A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine